Portfolio of Biotech Stocks: Second Portfolio

Here is a sample of 9 biotech stocks from the universe of biotechnology companies.


9 Biotech Stocks: Second Portfolio

Name
& Monthly Returns

Symbol
& Snapshot

Recent Prices
& Trendline Chart

AlkermesALKS
Ionis PharmaceuticalsIONS
Madrigal PharmaceuticalsMDCL
Neurocrine BiosciencesNBIX
RegenxbioRGNX
Sarepta TherapeuticsSRPT
Vanda PharmaceuticalsVNDA
Viking TherapueticsVKTX
Vir BiotechnologyVIR
Sparkline weekly price charts based on Alpha Vantage data.

9 Biotech Stocks: Second Portfolio

Name
& Last 100 Days Returns

Symbol

Last Close
& 100-Day Trendline Chart

AlkermesALKS$22.02
Ionis PharmaceuticalsIONS$42.27
Madrigal PharmaceuticalsMDCL$1.05
Neurocrine BiosciencesNBIX$101.36
RegenxbioRGNX$23.19
Sarepta TherapeuticsSRPT$108.33
Vanda PharmaceuticalsVNDA$9.44
Viking TherapueticsVKTX$2.60
Vir BiotechnologyVIR$18.75


Portfolio Values

To inspect the performance of the Biotech Stocks: Second Portfolio portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.

The 8 stocks included in the portfolio computations are: ALKS, IONS, MDCL, NBIX, RGNX, SRPT, VNDA and VKTX. The current value of the portfolio assumes that $1,250.00 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. VIR was excluded from the portfolio computations because of insufficient price data.

The current value of the $10,000 investment is $11,176. The percent return is 11.76%. The annualized return is 2.25%.


8 Biotech Stocks: Second Portfolio Returns

Name

Symbol

Monthly Returns & Details

AlkermesALKS-56.69%
Ionis PharmaceuticalsIONS-16.63%
Madrigal PharmaceuticalsMDCL3.96%
Neurocrine BiosciencesNBIX65.40%
RegenxbioRGNX-29.62%
Sarepta TherapeuticsSRPT138.82%
Vanda PharmaceuticalsVNDA-47.26%
Viking TherapueticsVKTX36.13%


Portfolio Value Chart for Last 100 Daily Closes



Related Portfolios

Portfolio of Biotech Stock: First Portfolio

Portfolio of Biotech Stocks: Diabetes

Portfolio of Large Biotech Stocks